Fixturin

Trade name: Fixtrin

Small moleculeapproved

Approved

Jun 15, 2020

Fixturin is a synthetic small-molecule fixture drug used to validate CDEK query behavior end-to-end. — ChEMBL

Clinical trial activity

2 trials · 1 clinical orgs · 1 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0

Earliest trial started Mar 1, 2015 (NCT90000001)

Timeline

2010s

  1. Jan 1, 2015

    Fixture Pharmaceuticals — Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Fixture Pharmaceuticals — IND Organization

  3. Jan 1, 2015

    Fixture Pharmaceuticals — IND Organization

  4. Jan 1, 2019

    Fixture Pharmaceuticals — Earliest Phase 3 Sponsor(trial)

2020s

  1. Jun 15, 2020

    Fixture Pharmaceuticals — Earliest FDA Approval

  2. Jun 15, 2020

    Fixture Pharmaceuticals — NDA Organization

  3. Jul 1, 2020

    Evidence of US Marketing

  4. Jul 1, 2020

    Fixture Pharmaceuticals — Marketing Organization

Indications

Mechanism of action

Approval history

  • marketedJul 1, 2020
  • approvedPriority reviewJun 15, 2020

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
Mol. weight
206.28 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
None
Inorganic
No
Polymer
No
Class
Analgesic
Delivery
Oral tablet
Availability
Prescription
Multi-specific
No (Mono-specific)

Oral

Yes

Parenteral

No

Topical

No

First in class

Sources

Also known as

  • Fixtrin
  • Fixturin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT90000002Phase 3Apr 1, 2019Fixture Pharmaceuticals
NCT90000001Phase 1Mar 1, 2015Fixture Pharmaceuticals
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Fixture PharmaceuticalsFor profit2012015
1 organizations
Page 1 / 1

Marketing (3)

OrganizationOrg typeRelationshipDate
Fixture PharmaceuticalsFor profitINDJan 1, 2015
Fixture PharmaceuticalsFor profitNDAJun 15, 2020
Fixture PharmaceuticalsFor profitMKTGJul 1, 2020